Navigation Links
Antibody Finding Might Help in Search for HIV Vaccine
Date:7/14/2011

By Randy Dotinga
HealthDay Reporter

THURSDAY, July 14 (HealthDay News) -- Researchers report that they've gained insight into the workings of the immune system's response to HIV, the AIDS virus, in certain people, potentially providing a boost as scientists work toward a vaccine.

The findings won't have an immediate big impact on either vaccine research or HIV treatment. However, they do reveal how soldiers of the immune system known as antibodies use special powers to combat the virus in some patients, said study co-author Dr. Michel C. Nussenzweig, a professor of immunology at The Rockefeller University in New York City.

Ultimately, he said, scientists could develop a vaccine that teaches people's bodies how to make the antibodies. "You'd try to make them do it themselves," he said, instead of pumping antibodies into the body.

Since the late 1990s, AIDS has largely become a treatable, chronic disease. But it can still be deadly, and many scientists think they're years away from developing a vaccine to prevent people from becoming infected in the first place.

In the new study, published online July 14 in Science, researchers focused on antibodies that are produced only in certain patients with HIV. They work by preventing the virus from picking the locks in cells that are supposed to keep germs out.

The problem is that the antibodies don't help cells that have already been infected, Nussenzweig said. And the antibodies only appear about two to three years after someone has been infected with the virus, he said. It's not clear how much the antibodies help those people.

Nussenzweig and colleagues were able to clone the antibodies from four patients. "It's possible that if you were to have enough of these things, there might even be a therapy" for people with the virus, he said. In other words, the antibodies could become part of a drug.

However, the antibodies don't live long, meaning patients would have to undergo repeated and regular treatments if they wanted the protection they may be able to provide, he said. For now, he said, the research seems more likely to help the development of a vaccine.

U.S. National Institutes of Health vaccine researcher Dr. John Mascola said the findings extend "prior work to show that the human immune system can make antibodies that target vulnerable regions of HIV."

Dr. Jonathan D. Fuchs, director of Vaccine Studies at the San Francisco Department of Public Health, said the findings represent an "important advance" because they help define the types of antibodies that vaccines need to elicit in the body.

More information

For more about HIV/AIDS, visit the U.S. National Library of Medicine.

SOURCES: Michel C. Nussenzweig, Ph.D., M.D., professor, immunology, Rockefeller University and Howard Hughes Medical Institute, New York City; John R. Mascola, M.D., Vaccine Research Center, U.S. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.; Jonathan D. Fuchs, M.D., M.P.H., director, Vaccine Studies, San Francisco Department of Public Health; July 14, 2011, Science, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Disorderly enzyme is key for antibody diversity
2. Combination antibody therapy shows promise in metastatic melanoma
3. Antibody-guided drug works against acute lymphoblastic leukemia
4. Antibody production gets confused during long-term spaceflight
5. Tiny antibody fragments raised in camels find drug targets in human breast cancer cells
6. Tufts receives patent for antibody treatment against hemolytic uremic syndrome
7. HJF signs distribution agreement for antibody to evaluate prostate cancer
8. Antibody Linked to Allergies on the Rise
9. Antibody therapy lengthens survival of metastatic melanoma patients in large clinical trial
10. Fox Chase clinical trial tests first of its kind antibody
11. NIH supports new research strategy for finding a cure for HIV
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Antibody Finding Might Help in Search for HIV Vaccine
(Date:2/5/2016)... ... February 05, 2016 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... once again host, Swirl, A Wine Tasting Event at the La Gorce Country ...
(Date:2/5/2016)... ... ... Give To Cure today announced that it is working with ... campaign that is crowdfunding clinical trials to help find cures faster for Alzheimer’s Disease. ... device. In 2015 alone, Venmo processed $7.5 billion in transactions among users. , Give ...
(Date:2/5/2016)... ... 05, 2016 , ... Stuart Bentkover, MD, FACS is thrilled to ... the most effective tattoo removal today, Dr. Bentkover is the only doctor in Central ... the PicoSure has been approved by the Food and Drug Administration (FDA) as a ...
(Date:2/5/2016)... ... February 05, 2016 , ... California Mobile Kitchens , ... of their latest mobile kitchen model, featuring customizable stainless steel interiors and a ... kitchens for use anywhere in the U.S. Many of their units can be ...
(Date:2/5/2016)... ... 2016 , ... Susan Polk Health Insurance Company recently released a ... see in 2016. To view the report, see below, or visit Susan Polk's ... Luis Obispo seniors who rely on Medicare health insurance and whose monthly income includes ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... -- France , Germany , ... Israel ). It includes a 10-year epidemiology forecast for ... by age and sex in these markets. GD epidemiology report is written ... high quality, transparent and market-driven, providing expert analysis of disease trends in ... , Italy , Spain , ...
(Date:2/4/2016)... -- The Senior Care Pharmacy Coalition (SCPC) today commended ... Jason Chaffetz (R-UT) and Ranking Member Elijah ... "Developments in the Prescription Drug Market," to examine ... abusive pharmacy benefit manager (PBM) pricing practices. ... Elijah Cummings (D-MD) are diligent, serious lawmakers committed ...
(Date:2/4/2016)... Wegener Polyangiitis - Pipeline Review, H2 ... Polyangiitis - Pipeline Review, H2 2015, provides an ... This report provides comprehensive information on the therapeutic ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ...
Breaking Medicine Technology: